Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | NR2E3 | Q9Y5X4 | 3/20 | 0.52 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | ABL1 | P00519 | 7/20 | 0.43 |
| ▸ | RIN1 | Q13671 | 7/20 | 0.43 |
| ▸ | NSD2 | O96028 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | IDE | P14735 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13079425 | 1.00 | TDP1 (0.52) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13049469 | 1.00 | TDP1 (0.52) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13894719 | 0.95 | TDP1 (0.50) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13894631 | 0.92 | TDP1 (0.51) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13079434 | 0.84 | TDP1 (0.51) | TDP1KEAP1 | |
| SCHEMBL13049455 | 0.84 | TDP1 (0.51) | TDP1KEAP1 | |
| SCHEMBL13079659 | 0.83 | TDP1 (0.48) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13079435 | 0.82 | KEAP1 (0.35) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13049585 | 0.82 | KEAP1 (0.35) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 | |
| SCHEMBL13049468 | 0.82 | KEAP1 (0.35) | TDP1ALDH1A1NR2E3MAPK10L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100297113-A1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | PURDUE RESEARCH FOUNDATION | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297113-A1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | APEX1, NQO1, REV1 | TDP1 118/4885ALDH1A1 210/4885NR2E3 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.